A Phase 3 Study Comparing Dinaciclib Versus Ofatumumab in Patients With Refractory Chronic Lymphocytic Leukemia (P07714)

Clinical trial NCT01580228 · COMPLETED

Trial details

NCT number: NCT01580228
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia (CLL)

Start date: 2012-08-01
Primary completion: 2014-12-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.